Table 1. Baseline characteristics according to disease outcome in CMV PCR positive patients.
| Non-survivors (n = 26) | Survivors (n = 47) | p-value | |
|---|---|---|---|
| Age (years) | 64.0 (49.0–72.0) | 58.0 (43.2–66.0) | 0.271 |
| Female sex, n (%) | 17 (65.3) | 31 (65.9) | 0.960 |
| CMV-DNA (copies/mL) | 95,500.0 (5150.0–315,000.0) | 6700.0 (3995.0–40,950.0) | 0.005 |
| WBC count (/μL) | 8620.0 (5490.0–12,480.0) | 8270.0 (4940.0–14,020.0) | 0.670 |
| Neutrophil count (/μL) | 8045.0 (4860.0–11,210.0) | 7210.0 (4090.0–12,330.0) | 0.397 |
| Lymphocyte count (/μL) | 415.0 (260.0–620.0) | 420.0 (190.0–890.0) | 0.895 |
| Hemoglobin (g/dL) | 10.0 (9.0–10.0) | 10.0 (8.0–11.0) | 0.683 |
| Platelet count (/103 μL) | 129.0 (77.0–242.0) | 198.0 (119.0–322.0) | 0.106 |
| BUN (mg/dL) | 29.0 (18.0–47.0) | 21.0 (11.0–34.0) | 0.040 |
| Cr (mg/dL) | 1.0 (1.0–2.0) | 1.0 (1.0–1.0) | 0.444 |
| Total protein (mg/dL) | 5.0 (4.0–5.0) | 5.0 (5.0–6.0) | 0.025 |
| Albumin (mg/dL) | 2.0 (2.0–3.0) | 3.0 (2.0–3.0) | 0.007 |
| ESR (mm/hr) | 27.0 (6.0–92.0) | 53.0 (17.0–83.0) | 0.284 |
| CRP (mg/L) | 54.0 (31.0–97.0) | 52.0 (5.0–114.0) | 0.565 |
Values are expressed as medians (Q1–Q3) or counts (%). P-values are based on the Mann-Whitney U test, chi-squared test, or Fisher’s exact test. BUN, blood urea nitrogen; CMV, cytomegalovirus; Cr, creatinine; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; WBC, white blood cell.